Alterations in myocardial free fatty acid clearance precede mechanical abnormalities in canine tachycardia-induced heart failure

Gregory L. Freeman, James T. Colston, Donald D Miller

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: The purpose of this study was to evaluate whether abnormalities of free fatty acid metabolism are present before the onset of overt mechanical dysfunction in dogs with tachycardia-induced heart failure. We studied six dogs chronically instrumented to allow assessment of left ventricular function in the pressure-volume plane. Methods and Results: Free fatty acid clearance was assessed according to the washout rate of a free fatty acid analog, iodophenylpentadecanoic acid ([123I]PPA or IPPA). IPPA clearance was measured within 1 hour of the hemodynamic assessment. The animals were studied under baseline conditions and 11.7±3.6 days after ventricular pacing at a rate of 240 beats/min. Hemodynamic studies after pacing showed a nonsignificant increase in left ventricular end-diastolic pressure (11.7±4.7 to 17.4±6.5 mm Hg) and a nonsignificant decrease in the maximum derivative of pressure with respect to time (1836±164 vs 1688±422 mm Hg/sec). There was also no change in the time constant of left ventricular relaxation, which was 34.8±7.67 msec before and 35.3±7.3 msec after pacing. However, a significant prolongation in the clearance half-time of [123I]PPA, from 86.1±23.9 to 146.5±22.6 minutes (p<0.01) was found. Thus abnormal lipid clearance appears before the onset of significant mechanical dysfunction in tachycardia-induced heart failure. Conclusion: This suggests that abnormal substrate metabolism may play an important role in the pathogenesis of this condition.

Original languageEnglish (US)
Pages (from-to)171-179
Number of pages9
JournalJournal of Nuclear Cardiology
Volume1
Issue number2
DOIs
StatePublished - Jan 1 1994
Externally publishedYes

Fingerprint

Nonesterified Fatty Acids
Tachycardia
Canidae
Heart Failure
Hemodynamics
Dogs
Pressure
Left Ventricular Function
Blood Pressure
Lipids
Acids
omega-(4-iodophenyl)pentadecanoic acid

Keywords

  • cardiac metabolism
  • contractility
  • depression
  • energetics
  • myocardial

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Alterations in myocardial free fatty acid clearance precede mechanical abnormalities in canine tachycardia-induced heart failure. / Freeman, Gregory L.; Colston, James T.; Miller, Donald D.

In: Journal of Nuclear Cardiology, Vol. 1, No. 2, 01.01.1994, p. 171-179.

Research output: Contribution to journalArticle

@article{3f9697b9ccff4c5bacdde3e38339f642,
title = "Alterations in myocardial free fatty acid clearance precede mechanical abnormalities in canine tachycardia-induced heart failure",
abstract = "Background: The purpose of this study was to evaluate whether abnormalities of free fatty acid metabolism are present before the onset of overt mechanical dysfunction in dogs with tachycardia-induced heart failure. We studied six dogs chronically instrumented to allow assessment of left ventricular function in the pressure-volume plane. Methods and Results: Free fatty acid clearance was assessed according to the washout rate of a free fatty acid analog, iodophenylpentadecanoic acid ([123I]PPA or IPPA). IPPA clearance was measured within 1 hour of the hemodynamic assessment. The animals were studied under baseline conditions and 11.7±3.6 days after ventricular pacing at a rate of 240 beats/min. Hemodynamic studies after pacing showed a nonsignificant increase in left ventricular end-diastolic pressure (11.7±4.7 to 17.4±6.5 mm Hg) and a nonsignificant decrease in the maximum derivative of pressure with respect to time (1836±164 vs 1688±422 mm Hg/sec). There was also no change in the time constant of left ventricular relaxation, which was 34.8±7.67 msec before and 35.3±7.3 msec after pacing. However, a significant prolongation in the clearance half-time of [123I]PPA, from 86.1±23.9 to 146.5±22.6 minutes (p<0.01) was found. Thus abnormal lipid clearance appears before the onset of significant mechanical dysfunction in tachycardia-induced heart failure. Conclusion: This suggests that abnormal substrate metabolism may play an important role in the pathogenesis of this condition.",
keywords = "cardiac metabolism, contractility, depression, energetics, myocardial",
author = "Freeman, {Gregory L.} and Colston, {James T.} and Miller, {Donald D}",
year = "1994",
month = "1",
day = "1",
doi = "10.1007/BF02984089",
language = "English (US)",
volume = "1",
pages = "171--179",
journal = "Journal of Nuclear Cardiology",
issn = "1071-3581",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Alterations in myocardial free fatty acid clearance precede mechanical abnormalities in canine tachycardia-induced heart failure

AU - Freeman, Gregory L.

AU - Colston, James T.

AU - Miller, Donald D

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Background: The purpose of this study was to evaluate whether abnormalities of free fatty acid metabolism are present before the onset of overt mechanical dysfunction in dogs with tachycardia-induced heart failure. We studied six dogs chronically instrumented to allow assessment of left ventricular function in the pressure-volume plane. Methods and Results: Free fatty acid clearance was assessed according to the washout rate of a free fatty acid analog, iodophenylpentadecanoic acid ([123I]PPA or IPPA). IPPA clearance was measured within 1 hour of the hemodynamic assessment. The animals were studied under baseline conditions and 11.7±3.6 days after ventricular pacing at a rate of 240 beats/min. Hemodynamic studies after pacing showed a nonsignificant increase in left ventricular end-diastolic pressure (11.7±4.7 to 17.4±6.5 mm Hg) and a nonsignificant decrease in the maximum derivative of pressure with respect to time (1836±164 vs 1688±422 mm Hg/sec). There was also no change in the time constant of left ventricular relaxation, which was 34.8±7.67 msec before and 35.3±7.3 msec after pacing. However, a significant prolongation in the clearance half-time of [123I]PPA, from 86.1±23.9 to 146.5±22.6 minutes (p<0.01) was found. Thus abnormal lipid clearance appears before the onset of significant mechanical dysfunction in tachycardia-induced heart failure. Conclusion: This suggests that abnormal substrate metabolism may play an important role in the pathogenesis of this condition.

AB - Background: The purpose of this study was to evaluate whether abnormalities of free fatty acid metabolism are present before the onset of overt mechanical dysfunction in dogs with tachycardia-induced heart failure. We studied six dogs chronically instrumented to allow assessment of left ventricular function in the pressure-volume plane. Methods and Results: Free fatty acid clearance was assessed according to the washout rate of a free fatty acid analog, iodophenylpentadecanoic acid ([123I]PPA or IPPA). IPPA clearance was measured within 1 hour of the hemodynamic assessment. The animals were studied under baseline conditions and 11.7±3.6 days after ventricular pacing at a rate of 240 beats/min. Hemodynamic studies after pacing showed a nonsignificant increase in left ventricular end-diastolic pressure (11.7±4.7 to 17.4±6.5 mm Hg) and a nonsignificant decrease in the maximum derivative of pressure with respect to time (1836±164 vs 1688±422 mm Hg/sec). There was also no change in the time constant of left ventricular relaxation, which was 34.8±7.67 msec before and 35.3±7.3 msec after pacing. However, a significant prolongation in the clearance half-time of [123I]PPA, from 86.1±23.9 to 146.5±22.6 minutes (p<0.01) was found. Thus abnormal lipid clearance appears before the onset of significant mechanical dysfunction in tachycardia-induced heart failure. Conclusion: This suggests that abnormal substrate metabolism may play an important role in the pathogenesis of this condition.

KW - cardiac metabolism

KW - contractility

KW - depression

KW - energetics

KW - myocardial

UR - http://www.scopus.com/inward/record.url?scp=0027973105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027973105&partnerID=8YFLogxK

U2 - 10.1007/BF02984089

DO - 10.1007/BF02984089

M3 - Article

C2 - 9420684

AN - SCOPUS:0027973105

VL - 1

SP - 171

EP - 179

JO - Journal of Nuclear Cardiology

JF - Journal of Nuclear Cardiology

SN - 1071-3581

IS - 2

ER -